DrugPatentWatch Database Preview
Drugs in Development Information for Hetrombopag
» See Plans and Pricing
What is the drug development status for Hetrombopag?
Hetrombopag is an investigational drug.
There have been 12 clinical trials for Hetrombopag.
The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2019.
The most common disease conditions in clinical trials are Purpura, Thrombocytopenic, Idiopathic, Purpura, Thrombocytopenic, and Purpura. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd. and [disabled in preview].
There are three US patents protecting this investigational drug.
Summary for Hetrombopag
| US Patents | 3 |
| International Patents | 0 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2019-02-01) |
| Vendors | 6 |
Recent Clinical Trials for Hetrombopag
| Title | Sponsor | Phase |
|---|---|---|
| Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
Clinical Trial Summary for Hetrombopag
Top disease conditions for Hetrombopag
Top clinical trial sponsors for Hetrombopag
US Patents for Hetrombopag
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hetrombopag | Get Started for $10 | Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof | Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai, CN) | Get Started for $10 |
| Hetrombopag | Get Started for $10 | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN) | Get Started for $10 |
| Hetrombopag | Get Started for $10 | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN) | Get Started for $10 |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
